Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New needle angle could mean less back pain for millions

NCT ID NCT06283628

Symptom relief Sponsor: Milton S. Hershey Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests two different methods of radiofrequency ablation (a procedure that uses heat to calm pain nerves) for people with long-term low back pain. The standard method uses a slight angle, while the new method places the needle more straight in from the back. Researchers will compare how well each method reduces pain and improves daily function in 25 adults.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Radiofrequency ablation procedure
What this could lead to
If successful, this could identify a more effective way to perform radiofrequency ablation for chronic low back pain, leading to better pain relief and function.
What could go wrong
This is a small, early-stage study with only 25 participants, so results may not apply to everyone. The new approach might not be better than the standard one.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Bilateral equally intense axial low back pain 2. Pain duration of ≥ 6 months 3. Three-day average NRS scores of ≥ 3/10 4. Age greater than 18 years 5. Failure of conservative treatment, including nonsteroidal anti-inflammatory medications and physical therapy 6. Positive response to a series of two bilateral diagnostic lumbar medial branch nerve blocks (≥ 80% pain relief). This is the current standard of care. Exclusion Criteria: 1. Radicular pain below the knee 2. Systemic infection or localized infection at the anticipated introducer entry site 3. Pregnancy 4. Allergy to Lidocaine 5. Bleeding dyscrasias 6. Patients unable to give informed consent 7. History of lumbar spine surgery at the affected levels 8. History of previous bilateral lumbar RFA of medial branches within the past six months. 9. Significant comorbid somatization or widespread pain with central sensitization 10. Secondary gain identified due to ongoing legal proceedings or worker's compensation 11. Cognitive impairment 12. Any pre-existing condition at the discretion of the provider that may confound interpretation of results -

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lumbar spondylosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

spondylosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lumbar spondylosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Penn State Hershey College of Medicine

    Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.